Cargando…
Treatment of SARS with human interferons
Autores principales: | Antonelli, Guido, Scagnolari, Carolina, Vicenzi, Elisa, Clementi, Massimo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2003
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7134736/ https://www.ncbi.nlm.nih.gov/pubmed/14550714 http://dx.doi.org/10.1016/S0140-6736(03)14482-0 |
Ejemplares similares
-
Type I interferon and HIV: Subtle balance between antiviral activity, immunopathogenesis and the microbiome
por: Scagnolari, Carolina, et al.
Publicado: (2018) -
Twenty-five years of type I interferon-based treatment: A critical analysis of its therapeutic use
por: Antonelli, Guido, et al.
Publicado: (2015) -
IN VITRO ASSESSMENT OF THE BIOLOGIC ACTIVITY OF INTERFERON BETA FORMULATIONS USED FOR THE TREATMENT OF RELAPSING MULTIPLE SCLEROSIS
por: Scagnolari, Carolina, et al.
Publicado: (2014) -
Naringenin is a powerful inhibitor of SARS-CoV-2 infection in vitro
por: Clementi, Nicola, et al.
Publicado: (2021) -
Type I interferons can be detected in respiratory swabs from SARS-Cov-2 infected patients
por: Antonelli, Guido, et al.
Publicado: (2020)